Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2026)

Viemed Healthcare filings provide 8 years of Liabilities and Shareholders Equity readings, the most recent being $199.2 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 12.47% to $199.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $764.2 million, a 14.84% increase, with the full-year FY2025 number at $199.2 million, up 12.47% from a year prior.
  • Liabilities and Shareholders Equity hit $199.2 million in Q4 2025 for Viemed Healthcare, down from $202.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $202.4 million in Q3 2025 to a low of $111.0 million in Q2 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $149.3 million (2023), compared with a mean of $146.8 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: fell 1.04% in 2021 and later soared 32.34% in 2023.
  • Viemed Healthcare's Liabilities and Shareholders Equity stood at $118.0 million in 2021, then fell by 0.78% to $117.0 million in 2022, then skyrocketed by 32.34% to $154.9 million in 2023, then increased by 14.32% to $177.1 million in 2024, then grew by 12.47% to $199.2 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $199.2 million (Q4 2025), $202.4 million (Q3 2025), and $184.6 million (Q2 2025) per Business Quant data.